Ferumoxytol-Enhanced Cardiac Magnetic Resonance Angiography and 4D Flow: Safety and Utility in Pediatric and Adult Congenital Heart Disease
Round 1
Reviewer 1 Report
This is a well written review covered adequate knowledge in the field, I appreciate the work.
Author Response
Thank you for your kind review of the manuscript and your feedback.
Reviewer 2 Report
Authors have nicely addressed innovations in ferumoxytol enhanced CMR in patients with congenital heart diseases. Despite the fact that recent studies are limited - involving limited number of patients- authors have gathered and present the existing literature.
I believe that authors should perform minor changes, mainly to enhance the understandability of their manuscript.
· A table (or figure) ferumoxytol versus gadolinium should be added reporting the pros and cons of each contrast media.
· A table with the disease- specific features that render ferumoxytol a better choice than gadolinium for CMR imaging.
Author Response
Thank you for your feedback on the manuscript. We have added the two requested Tables (Table 2 and Table 3). We have uploaded the updated Clean version of the manuscript.